MHC class II expression in double mutant mice lacking invariant chain and DM functions

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 606-614

  Kenty, George ^a   Martin, W David ^b,c   Van Kaer, Luc ^c,d   Bikoff, Elizabeth K ^a  

^a HARVARD UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN STRUCTURE; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ATP-BINDING CASSETTE TRANSPORTERS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DIMERIZATION; GENE DELETION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; SPLEEN;

EID: 0031964714     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Ann. Rev. Cell Dev. Biol. 11:267.
2. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505.
3. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
4. Schaiff, W. T., K. A. Hruska, Jr., D. W. McCourt, M. Green, and B. D. Schwartz. 1992. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176:657.
5. Anderson, K. S., and P. Cresswell. 1994. A role for calnexin IP90 in the assembly of class II MHC molecules. EMBO J. 13:675.
6. Bonnerot, C., M. S. Marks, P. Cosson, E. J. Robertson, E. K. Bikoff, R. N. Germain, and J. S. Bonifacino. 1994. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13:934.
7. Nijenhuis, M., and J. Neefjes. 1994. Early events in the assembly of major histocompatibility complex class H heterotrimers from their free subunits. Eur. J. Immunol. 24:247.
8. Schreiber, K. L., M. P. Bell, C. J. Huntoon, S. Rajagopaian, M. B. Brenner, and D. J. McKean. 1994. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. Int. Immunol. 6:101.
9. Layet, C., and R. N. Germain. 1991. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA 88:2346.
10. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
11. Baake, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
12. Lotteau, V., L. Teyton, T. Peleraux, L. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
13. Roche, P. A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88:3150.
14. Roche, P. A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity 3:259.
15. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
16. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.
17. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
18. Kropshofer, H., S. O. Arndt, G. Moklenhauer, G. J. Hammerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293.
19. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hammerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144.
20. van Ham, S. M., U. Gruneberg, G. Malcherek, I. Broker, A. Melms, and J. Trowsdale. 1996. Human histocompatibility leukocyte antigen HLA-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184:2019.
21. Lindstedt, R., M. Liljedahl, A. Peleraux, P. A. Peterson, and L. Karlsson. 1995. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3:561.
22. Marks, M. S., P. A. Roche, E. van Donselaar, L. Woodruff, P. J. Peters, and J. S. Bonifacino. 1995. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131:351.
23. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
24. Viville, S., J. Neefjes, V. Loeteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
25. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
26. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules antigen presentation, and T cell repertoire selection. Cell 84: 543.
27. Miyazaki, T., P. Wolf, S. Tourne, C. Waltziner, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
28. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-delicient mice. Science 271:1278.
29. + T cells. Cell 71:1205.
30. Kontgen, F., G. Suss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5:957.
31. Janeway, C. A., Jr., P. J. Conrad, E. A. Lerner, J. Babich, P. Wettstein, and D. B. Murphy. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
32. Murphy, D. B., D. Lo, S. Rath, R. L. Brinster, R. A. Flavell, A. Slanetz, and C. A. Janeway, Jr. 1989. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature 338:765.
33. Eastman, S., M. Deftos, P. C. DeRoos, D.-H. Hsu, L. Teyton, N. S. Braunstein, C. J. Hacken, and A. Rudensky. 1996. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur. J. Immunol. 26:385.
34. Symington, F. W., and J. Sprent. 1981. A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion. Immunogenetics 14:53.
35. Bhattacharya, A., M. E. Dorf, and T. A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:2488.
36. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
37. Hugo, P., J. W. Kappler, D. I. Godfrey, and P. C. Marrack. 1992. A cell line that can induce thymocyte positive selection. Nature 360:679.
38. Rudensky, A. Y., P. Preston-Hurlburt, B. K. Al-Ramadi, J. Rothbard, and C. A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429.
39. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106.
40. Rao, M., W. T. Lee, and D. H. Conrad. 1987. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunol. 138:1845.
41. Waldschmidt, T. J., D. H. Conrad, and R. G. Lynch. 1988. The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor. J. Immunol. 140:2148.
42. Dornmair, K., and H. M. McConnell. 1990. Refolding and reassembly of separate α and β chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity. Proc. Natl. Acad. Sci. USA 87:4134.
43. Stern, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465.
44. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
45. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex MHC class II transport through the secretory pathway redefines the primary function of class II-Associated invariant chain peptides CLIP. J. Exp. Med. 184:2061.
46. Androlewicz, M. J., and P. Cresswell. 1996. How selective is the transporter associated with antigen processing? Immunity 5:1.
47. Momburg, F., J. Roelse, G. J. Hammerling, and J. J. Neefjes. 1994. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179:1613.
48. Tourne, S., H. M. van Santen, M. van Roon, A. Berns, C. Benoist, D. Mathis, and H. Ploegh. 1996. Biosynthesis of major histocompatibility complex molecules and generation of T cells in Ii TAP1 double-mutant mice. Proc. Natl. Acad. Sci. USA 93:1464.
49. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Engelhard. 1992. HLA-A2,1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264.
50. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
51. Busch, R., I. Y. Vturina, J. Drexler, F. Momburg, and G. J. Hammerling. 1995. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain. Eur. J. Immunol. 25:48.
52. Busch, R., I. Cloutier, R.-P. Sekaly, and G. J. Hammerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
53. Zhong, G., P. Romagnoli, and R. N. Germain. 1997. Related leucine-based cytoplasms targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185::429.
54. Kearney, J. F., M. D. Cooper, J. Klein, E. R. Abney, R. M. E. Parkhouse, and A. R. Lawton. 1977. Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J. Exp. Med. 146:297.
55. Mond, J. J., E. Seghal, J. Kung, and F. D. Finkelman. 1981. Increased expression of I-region-associated antigen Ia on B cells after cross-linking of surface immunoglobulin. J. Immunol. 127:881.
56. Davidson, H. W., P. A. Reid, A. Lanzavecchia, and C. Watts. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105.
57. Bonnerot, C., D. Lankar, D. Hanau, D. Spehner, J. Davoust, J. Salamero, and W. H. Fridman. 1995. Role of B cell receptor Igα and Igβ subunits in MHC class II-restricted antigen presentation. Immunity 3:335.
58. Hayakawa, K., D. Tarlinton, and R. R. Hardy. 1994. Absence of MHC class II expression distinguishes fetal from adult B lymphopoiesis in mice. J. Immunol. 152:4801.
59. Lam, K.-P., and A. M. Stall. 1994. Major histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny. J. Exp. Med. 180:507.
60. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
61. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
62. Markowitz, J. S., P. R. Rogers, M. J. Grusby, D. C. Parker, and L. H. Glimcher. 1993. B lymphocyte development and activation independent of MHC class II expression. J. Immunol. 150:1223.
63. Nadimi, F., J. Moreno, F. Momburg, A. Heuser, S. Fuchs, L. Adorini, and G. Hammerling. 1991. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol. 21:1255.
64. Bikoff, E. K. 1992. Formation of complexes between self peptides and MHC class II molecules in cells defective for presentation of exogenous protein anti-gens. J. Immunol. 149:1.
65. Peterson, M., and J. Miller. 1992, Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
66. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284.
67. Pinet, V., M. S. Malnati, and E. O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852.
68. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603.
69. Lindner, R., and E. R. Unanue. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15:6910.
70. k class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153: 5382.
71. Stebbins, C. C., G. E. Loss, Jr., C. G. Elias, A. Chervonsky, and A. J. Sant. 1995. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181:223.
72. Bijlmakers, M. J. E., P. Benaroch, and H. L. Ploegh. 1994. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 13:2699.
73. Hedley, M. L., R. G. Urban, and J. L. Strominger. 1994. Assembly and peptide binding of major histocompatibilitv complex class II heterodimers in an in vitro translation system. Proc. Natl. Acad. Sci. USA 91:10479.
74. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615.
75. Teyton, L., D. O. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39.
76. Roche, P. A., C. L. Teletski, D. R. Karp, Pinet, V., Bakke, O., and E. O. Long. 1992. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11:2841.
77. Katz, J. F., C. Stebbins, E. Appella, and A. J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex MHC class II molecules. J. Exp. Med. 184:1747.
78. Lightstone, L., R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler. 1997. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94:5772.
79. Simonsen, A., F. Momburg, J. Drexler, G. Hammerling, and O. Bakke. 1993. Intracellular distribution of the MHC class II molecules and the associated invariant chain Ii in different cell lines. Int. Immunol. 5:903.
80. Schneider, F.-J., B. Opel, W. Ballhausen, W. Henkes, P. Steinlein, and K. Reske. 1987. Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant interferon-γ-activated bone marrow-derived macrophages. Eur. J. Immunol. 17:1235.
81. Momburg, F., and P. Moller. 1988. Non-co-ordinate expression of HLA-DR antigens and invariant chain. Immunology 63:551.
82. Momburg, F., K. Koretz, A. Von Herbay, and P. Moller. 1988. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain: an immunohistological study on normal and chronically inflamed small intestine. Clin. Exp. Immunol. 72:367.
83. Vidal, K., C. Samarut, J.-P. Magaud, J.-P. Revillard, and D. Kaiserlian. 1993. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epthelial cells. J. Immunol. 151:4642.
84. Tourne, S., T. Miyazaki, P. Wolf, H. Ploegh, C. Benoist, and D. Mathis. 1997. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-zM complexes. Proc. Natl. Acad. Sci. USA 94:9255.